Curbstone Financial Management Corp Purchases 400 Shares of Danaher Co. (NYSE:DHR)

Curbstone Financial Management Corp boosted its position in shares of Danaher Co. (NYSE:DHR) by 11.2% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,966 shares of the conglomerate’s stock after buying an additional 400 shares during the quarter. Curbstone Financial Management Corp’s holdings in Danaher were worth $813,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kentucky Retirement Systems Insurance Trust Fund raised its holdings in Danaher by 11.6% in the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock worth $4,874,000 after purchasing an additional 2,202 shares in the last quarter. FAS Wealth Partners Inc. raised its holdings in Danaher by 20.6% in the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate’s stock worth $2,203,000 after purchasing an additional 1,639 shares in the last quarter. Channing Global Advisors LLC raised its holdings in Danaher by 42.8% in the 4th quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate’s stock worth $1,301,000 after purchasing an additional 1,698 shares in the last quarter. Van ECK Associates Corp raised its holdings in Danaher by 6,862.7% in the 4th quarter. Van ECK Associates Corp now owns 929,868 shares of the conglomerate’s stock worth $213,452,000 after purchasing an additional 916,513 shares in the last quarter. Finally, ICICI Prudential Asset Management Co Ltd bought a new position in Danaher in the 4th quarter worth $4,591,000. 79.05% of the stock is currently owned by institutional investors.

Insider Transactions at Danaher

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares in the company, valued at $611,036,665.92. This represents a 28.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Royal Bank of Canada restated an “outperform” rating and issued a $250.00 price objective on shares of Danaher in a report on Wednesday, April 23rd. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Monday. The Goldman Sachs Group reduced their target price on shares of Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 23rd. UBS Group reduced their target price on shares of Danaher from $275.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 23rd. Finally, Bank of America reduced their target price on shares of Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $248.17.

Danaher Stock Performance

Shares of NYSE DHR opened at $202.63 on Wednesday. The firm’s 50-day moving average price is $191.32 and its 200-day moving average price is $211.72. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a market cap of $145.02 billion, a PE ratio of 38.38, a PEG ratio of 2.66 and a beta of 0.77. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.63%. Danaher’s dividend payout ratio (DPR) is presently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.